Phase II trial of nilotinib in patients with metastatic malignant melanoma harboring KIT gene aberration: A multicenter trial of Korean cancer study group (UN10-06)

Su Jin Lee, Taemin Kim, Yu Jung Kim, Kee Taek Jang, Hyo Jin Lee, Soon Nam Lee, Mi Sun Ahn, In Gyu Hwang, Suee Lee, Moon Hee Lee, Jeeyun Lee

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of nilotinib in patients with metastatic malignant melanoma harboring KIT gene aberration: A multicenter trial of Korean cancer study group (UN10-06)'. Together they form a unique fingerprint.

Medicine & Life Sciences